<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00756353</url>
  </required_header>
  <id_info>
    <org_study_id>P04933</org_study_id>
    <nct_id>NCT00756353</nct_id>
  </id_info>
  <brief_title>Survey of Buprenorphine Use Among &quot;Out of Care&quot; Population in France (P04933)(COMPLETED)</brief_title>
  <official_title>Out of Care Patient Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indivior Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indivior Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was a survey of drug users who obtain buprenorphine from the black market and have
      used buprenorphine during the last month. Subjects were surveyed at various locations
      (streets, railway stations, etc.) with a few simple questions in order to describe the use of
      buprenorphine in this &quot;out of care&quot; population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants were found from various places and using a &quot;snow ball&quot; technique.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The objective of this survey is to describe quantitatively and qualitatively, the use of buprenorphine in the population who obtain buprenorphine only on black market or both on black market and in pharmacy.</measure>
    <time_frame>Not Applicable, cross-sectional description.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>This survey will provide data on patients in regards to their own experience in drug addiction.</measure>
    <time_frame>Not Applicable, cross-sectional description.</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">600</enrollment>
  <condition>Drug Addiction</condition>
  <arm_group>
    <arm_group_label>Wave 1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Wave 2</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The population in this survey includes drug users who are in the &quot;out of care&quot; population,
        found in various places (streets, railway stations) and via the &quot;snow ball&quot; technique.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Drug users who have obtained buprenorphine only on the black market or both on black
             market and in pharmacy.

        Exclusion Criteria:

          -  Patients who have obtained buprenorphine only from the pharmacy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2008</study_first_submitted>
  <study_first_submitted_qc>September 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2008</study_first_posted>
  <last_update_submitted>April 14, 2011</last_update_submitted>
  <last_update_submitted_qc>April 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Head, Clinical Trials Registry &amp; Results Disclosure Group</name_title>
    <organization>Schering-Plough</organization>
  </responsible_party>
  <keyword>Heroin</keyword>
  <keyword>Buprenorphine use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Buprenorphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

